date/time interval
- October 1, 2020 - September 30, 2025
Targeting immunodominant regions on platelet factor 4 for the diagnosis and treatment of heparin-induced thrombocytopenia
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 417690